Cui Jingrong Jean

Director at Turning Point Therapeutics, Inc.

Sold, on record
$40.5M
Dollars the filings state
Form 4 sales
21
Latest Jun 9, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Apr 8, 2020 2020

    Sold 55,500 shares at $44.87 ($2.5M)

    Cui Jingrong Jean, Director

    Sold 7.1% of holdings ($35.1M position)726,591 shares left1.6x usual sizeFiling

  2. 2 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Apr 13, 2020 +5 days

    Sold 12,208 shares at $47.60 ($581k)

    Cui Jingrong Jean, Director

    Sold 1.7% of holdings ($34.6M position)714,383 shares left0.3x usual sizeFiling

  3. 3 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Apr 24, 2020 +11 days

    Sold 21,000 shares at $51.57 ($1.1M)

    Cui Jingrong Jean, Director

    Sold 2.9% of holdings ($36.8M position)693,383 shares left0.6x usual sizeFiling

  4. 4 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    May 7, 2020 +13 days

    Sold 55,500 shares at $53.27 ($3M)

    Cui Jingrong Jean, Director

    Sold 8% of holdings ($36.9M position)637,883 shares left1.7x usual sizeFiling

  5. 5 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    May 8, 2020 +1 day

    Sold 11,500 shares at $53.86 ($619k)

    Cui Jingrong Jean, Director

    Sold 1.8% of holdings ($34.4M position)626,383 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    May 21, 2020 +13 days

    Sold 21,000 shares at $59.18 ($1.2M)

    Cui Jingrong Jean, Director

    Sold 3.4% of holdings ($37.1M position)605,383 shares left0.6x usual sizeFiling

  7. 7 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Jun 8, 2020 +18 days

    Sold 55,500 shares at $64.16 ($3.6M)

    Cui Jingrong Jean, Director

    Sold 9.2% of holdings ($38.8M position)549,883 shares left1.7x usual sizeFiling

  8. 8 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Jun 9, 2020 +1 day

    Sold 9,500 shares at $65.81 ($625k)

    Cui Jingrong Jean, Director

    Sold 1.7% of holdings ($36.2M position)540,383 shares left0.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (21)

Form 144 notices and Form 4 sales by Cui Jingrong Jean
Source
Jun 9, 2020Jun 10, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale9,500$625k1.7%Plan not statedSEC
Jun 8, 2020Jun 8, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale55,500$3.6M9.2%Plan not statedSEC
May 21, 2020May 21, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale21,000$1.2M3.4%Plan not statedSEC
May 8, 2020May 12, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale11,500$619k1.8%Plan not statedSEC
May 7, 2020May 7, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale55,500$3M8.0%Plan not statedSEC
Apr 24, 2020Apr 24, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale21,000$1.1M2.9%Plan not statedSEC
Apr 13, 2020Apr 13, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale12,208$581k1.7%Plan not statedSEC
Apr 8, 2020Apr 8, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale55,500$2.5M7.1%Plan not statedSEC
Mar 26, 2020Mar 27, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale11,500$529k1.4%Plan not statedSEC
Mar 25, 2020Mar 25, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale31,792$1.4M3.9%Plan not statedSEC
Mar 12, 2020Mar 12, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale44,000$1.8M5.1%Plan not statedSEC
Feb 26, 2020Feb 26, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale21,000$1.1M2.4%Plan not statedSEC
Feb 13, 2020Feb 14, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale11,500$711k1.5%Plan not statedSEC
Feb 12, 2020Feb 12, 2020Turning Point Therapeutics, Inc.DirectorForm 4 sale55,500$3.6M6.5%Plan not statedSEC
Jan 29, 2020Jan 29, 2020Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale21,000$1.2M2.4%Plan not statedSEC
Jan 15, 2020Jan 17, 2020Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale11,500$611k1.3%Plan not statedSEC
Jan 14, 2020Jan 14, 2020Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale55,500$3M5.9%Plan not statedSEC
Dec 20, 2019Dec 20, 2019Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale48,500$3M4.9%Plan not statedSEC
Dec 17, 2019Dec 17, 2019Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale41,500$2.4M4.0%Plan not statedSEC
Dec 12, 2019Dec 12, 2019Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale34,500$1.9M3.3%Plan not statedSEC
Dec 9, 2019Dec 9, 2019Turning Point Therapeutics, Inc.Chief Scientific OfficerForm 4 sale118,500$6.1M10.0%Plan not statedSEC